Get the Stockscreener App
58.45
2.42%
-1.45
Eton Pharmaceuticals Inc stock is traded at $58.45, with a volume of 489.36K.
It is down -2.42% in the last 24 hours and up +27.54% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$59.90
Open:
$59.87
24h Volume:
489.36K
Relative Volume:
0.94
Market Cap:
$1.67B
Revenue:
$86.93M
Net Income/Loss:
$-1.48M
P/E Ratio:
-824.40
EPS:
-0.0709
Net Cash Flow:
$431.00K
1W Performance:
-2.22%
1M Performance:
+27.54%
6M Performance:
+233.43%
1Y Performance:
+227.08%
1-Day Range:
$56.93
$59.95
1-Week Range:
$56.93
$62.91
52-Week Range:
$14.27
$66.37
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
58.45 | 1.71B | 86.93M | -1.48M | 431.00K | -0.0709 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Eton Pharmaceuticals Inc (ETON) Stock Up 5.9% but GF Value Says Overvalued -- GF Score: 58/100 - GuruFocus
SEAN BRYNJELSEN Executes Sell Order: Offloads $6.09M In Eton Pharmaceuticals Stock - Benzinga
Eton Pharmaceuticals CEO Sean Brynjelsen Executes Four Stock Sales Over Two Days - Kalkine Media
Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock By Investing.com - Investing.com India
Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock - Investing.com
Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 1-Year HighWhat's Next? - MarketBeat
Forecast: Analysts Think Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Business Prospects Have Improved Drastically - simplywall.st
Danka Radosavljevic Net Worth (2026) - GuruFocus
Biotech Stocks At 52-Week HighsETON +44%, DXCM, ORKA, CON, ATAI - RTTNews
This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day - Stocktwits
Eton Pharmaceuticals Stock Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Responsive Playbooks and the ETON Inflection - Stock Traders Daily
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Sahm
Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes - StocksToTrade
Eton Pharmaceuticals Soars After Blowout Q2 And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars As Q2 Beat Triggers Aggressive Target Hikes - StocksToTrade
86,249 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Walleye Capital LLC - MarketBeat
Is Eton Pharmaceuticals (ETON) Fully Priced On Strong Q2 Results And Raised Guidance? - Yahoo Finance
Eton Pharmaceuticals (ETON) Soars 44% to $58.86: Battle at Resistance AheadDividend ETF - Vinanet
Why Eton Pharmaceuticals Is Top of the Class Today - The Motley Fool
Eton Pharmaceuticals Soars 39% After Earnings Beat and Upgraded Guidance - finance.biggo.com
ETON Stock Soars After Blowout Earnings And Guidance Hike - StocksToTrade
Eton Pharmaceuticals Stock Jumps 38% as Guidance Reset Tests Valuation - TechStock²
Eton Pharmaceuticals: No Reason Pharma Can't Deliver More Great Earnings Like These - Seeking Alpha
Eton Pharmaceuticals stock hits all-time high at 55.07 USD By Investing.com - Investing.com South Africa
Why is Eton Pharmaceuticals stock surging today? By Investing.com - Investing.com Canada
Eton Pharmaceuticals stock hits all-time high at 55.07 USD - Investing.com
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 1-Year High Following Earnings Beat - MarketBeat
Eton Pharmaceutical (ETON) Stock Forum and Discussion - Moomoo
Why is Eton Pharmaceuticals stock surging today? - Investing.com
Eton Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating - marketscreener.com
Applied Industrial Technologies To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday - benzinga.com
Eton Pharmaceuticals (ETON) Stock Reprices Higher After Profit Inflection - Sahm
ETON SWOT Analysis: Financial Insights from 10-Q Filing - GuruFocus
Eton Pharmaceuticals Q2 2026 Earnings Call Transcript - MarketBeat
Eton Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
ETON PHARMACEUTICALS ($ETON) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Earnings call transcript: Eton Pharmaceuticals tops Q2 2026 estimates, shares jump - Investing.com
Eton Pharmaceuticals, Inc. (ETON) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Eton Pharmaceuticals Q2 Results: Revenue up 99%, EBITDA margin expands to 43% - scanx.trade
Eton Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript - Benzinga
ETON: Record revenue, margin expansion, and portfolio growth drive raised 2026 guidance - TradingView
Eton Pharmaceuticals (NASDAQ:ETON) Releases Quarterly Earnings Results, Beats Expectations By $0.28 EPS - MarketBeat
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals soars 25% on earnings beat, raised guidance By Investing.com - Investing.com Australia
After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON - StreetInsider
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Eton Pharmaceuticals Inc Stock (ETON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MAIER PAUL V | Director |
Aug 28 '26 |
Sale |
59.07 |
50,000 |
2,953,572 |
59,745 |
1.66%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):